Pms-pirfenidone 267 & 801 Mg: Data Integrity Concerns With Products Bioequivalence Data That Could Lead To Incorrect Dosing.
Recall Summary PMS-PIRFENIDONE tablets in 267 mg and 801 mg strengths are being recalled across Canada due to data integrity issues with bioequivalence testing that could result in incorrect dosing. This is a Class I recall, indicating a serious quality concern with the drug's effectiveness. The recall affects all patients currently using these specific strengths of this medication.
- Product
- PMS-PIRFENIDONE 267 & 801 mg
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-06-07
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6f251477-eadf-4b7a-80dd-03fca3a7deaa